• Global Urethral Stricture Treatment Market, By Regions
• Urethral Stricture Treatment Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Urethral Stricture Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Urethral Stricture Treatment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Urethral Stricture Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Urethral Stricture Treatment Market - Market Dynamics
Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents,
dilators, and catheters is one of the major factors for rise in urethral stricture cases, which in
turn is driving growth of the urethral stricture treatment market.
According to the National Centers for Biotechnology & Information (NCBI), urethral stricture is
a common disease with prevalence of over 400 per 100,000 population among males in year
2016 globally. According to the Cancer Research UK, in males in the U.K., prostate cancer is
the most common cancer with around 47,200 new cases registered in 2015. Moreover, the
incidence rates of prostate cancer are projected to rise by 12% between 2014 and 2035, to 233
cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. High catheter
associated urinary tract infection (CAUTI) rates of 6.8 per 1000 device days were observed in
the UAE medical units in March 2015.
Moreover, advancements in development of therapies for treating urethral strictures is driving
growth of the urethral stricture treatment market. For instance, a Germany-based company,
MukoCell GmbH developed a tissue engineering-based product called MukoCell, which is used
for repair of urethral strictures and hypospadias. This product is an alternative to conventional
transplantation with native buccal mucosa.